s._IN The_DT growth_NN has_VBZ been_VBN fueled_VBN by_IN the_DT Food_NN and_CC Drug_NN Administrations_NNS -LRB-_-LRB- FDA_NNP -RRB-_-RRB- decision_NN to_TO grant_VB approval_NN in_IN 1998_CD for_IN a_DT CAD_NN system_NN that_WDT detected_VBD breast_NN cancer_NN lesions_NNS from_IN mammograms_NNS -LRB-_-LRB- scanned_VBN x-ray_NN images_NNS -RRB-_-RRB- =_JJ -_: =[_NN 19_CD -RRB-_-RRB- -_: =_SYM -_: ._.
Since_IN then_RB a_DT number_NN of_IN CAD_NNP systems_NNS have_VBP received_VBN FDA_NNP approval_NN ._.
Virtually_RB all_DT these_DT commercial_JJ CAD_NN systems_NNS focus_VBP on_IN detection_NN -LRB-_-LRB- or_CC more_RBR recently_RB diagnosis_NN -LRB-_-LRB- 7_CD -RRB-_-RRB- -RRB-_-RRB- of_IN breast_NN cancer_NN lesions_NNS for_IN mammography_NN
